Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.
作者信息
Weinerman B, Maxwell I, Hryniuk W
出版信息
Can Med Assoc J. 1974 Nov 16;111(10):1100-2.
Abstract
Cyclophosphamide was given intermittently rather than daily to 14 patients with autoimmune thrombocytopenic purpura. Eight patients responded and six did not. In those who responded the rise in platelet count was rapid, and in all patients the lack of toxicity was striking. Intermittent cyclophosphamide seems effective in some cases of autoimmune thrombocytopenia and is safe, at least in the short term. Controlled trials would be required to prove that intermittent is better than daily administration.
摘要
相似文献
1
Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.
Can Med Assoc J. 1974 Nov 16;111(10):1100-2.
2
Idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜
Neth J Med. 1974;17(3):140-52.
3
Treatment of idiopathic thrombocytopenic purpura in adults. Long-term results in a series of 41 patients.成人特发性血小板减少性紫癜的治疗。41例患者的长期结果。
Ann Clin Res. 1978 Apr;10(2):83-6.
4
"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.环磷酰胺成功治疗“难治性”血小板减少性紫癜。
JAMA. 1971 Jan 18;215(3):445-9.
5
Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.单一科室二十年特发性血小板减少性紫癜治疗经验：490例治疗结果
Haematologica. 1993 Nov-Dec;78(6 Suppl 2):22-8.
6
7
[Treatment of autoimmune thrombocytopenic purpura].[自身免疫性血小板减少性紫癜的治疗]
Minerva Med. 1982 Apr 28;73(18):1179-83.
8
[Idiopathic thrombocytopenic purpura: diagnosis and therapy in 46 patients].
Schweiz Med Wochenschr. 1983 Oct 8;113(40):1465-8.
9
[Splenectomy in idiopathic thrombocytopenic purpura: short- and long-term results (author's transl)].
Wien Klin Wochenschr. 1978 Mar 31;90(7):233-6.
10
Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.
Arch Invest Med (Mex). 1985 Jul-Sep;16(3):295-304.
引用本文的文献
1
[Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].[慢性特发性血小板减少性紫癜。当前治疗理念及病理生理、临床和诊断方面介绍]
Med Klin (Munich). 1998 Dec 15;93(12):707-18. doi: 10.1007/BF03044807.
2
Immunosuppressant therapy of idiopathic thrombocytopenic purpura.
Springer Semin Immunopathol. 1984;7(1):35-42. doi: 10.1007/BF01891778.
3
Treatment of idiopathic thrombocytopenic purpura.
Indian J Pediatr. 1986 Nov-Dec;53(6):685-9. doi: 10.1007/BF02748553.
4
Current concepts in the treatment of immune thrombocytopenia.
Drugs. 1990 Oct;40(4):531-42. doi: 10.2165/00003495-199040040-00004.
本文引用的文献
1
FOLIC ACID ANTAGONIST. EFFECTS ON THE CELL AND THE PATIENT. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.叶酸拮抗剂。对细胞和患者的影响。美国国立卫生研究院联合临床工作人员会议。
Ann Intern Med. 1963 Dec;59:931-56. doi: 10.7326/0003-4819-59-6-931.
2
Treatment of refractory idiopathic thrombocytopenic purpura.难治性特发性血小板减少性紫癜的治疗
JAMA. 1969 Mar 17;207(11):2049-52.
3
Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.已知抗血小板抗体与特发性紫癜中血小板减少症相关因素之间的相似性。生理学、血清学及同位素研究。
Ann N Y Acad Sci. 1965 Jun 30;124(2):499-542. doi: 10.1111/j.1749-6632.1965.tb18984.x.
4
"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.环磷酰胺成功治疗“难治性”血小板减少性紫癜。
JAMA. 1971 Jan 18;215(3):445-9.
5
Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone.对新西兰黑鼠-白鼠杂交小鼠的治疗研究。II. 硫唑嘌呤、环磷酰胺和甲基泼尼松龙的相对疗效。
Arthritis Rheum. 1972 May-Jun;15(3):247-52. doi: 10.1002/art.1780150305.
6
7
Cyclophosphamide-induced ovarian failure.
N Engl J Med. 1973 Nov 29;289(22):1159-62. doi: 10.1056/NEJM197311292892202.
8
Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy.
N Engl J Med. 1973 Jan 18;288(3):122-4. doi: 10.1056/NEJM197301182880303.
9
Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy.
N Engl J Med. 1971 Feb 11;284(6):290-4. doi: 10.1056/NEJM197102112840602.
10
Cytotoxic drugs in treatment of nonmalignant diseases.
Ann Intern Med. 1972 Apr;76(4):619-42. doi: 10.7326/0003-4819-76-4-619.
Zotero 插件